What is leptospirosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Leptospirosis?

Leptospirosis is a zoonotic bacterial infection caused by pathogenic spirochetes of the genus Leptospira, transmitted through contact with urine or reproductive fluids from infected animals, or through contaminated water and soil. 1, 2, 3

Disease Transmission and Epidemiology

Leptospirosis is a waterborne and zoonotic disease with global distribution, particularly prevalent in tropical and subtropical regions with humid, rainy climates. 1, 3 The disease represents a quintessential "one health" problem affecting humans and animals worldwide. 4

Transmission occurs through:

  • Direct contact with urine or reproductive fluids from infected animals (cattle, sheep, goats, dogs, rats, and other domestic or wild animals) 5, 6
  • Indirect contact with water or soil contaminated with urine from infected animals 2, 3
  • Penetration through mucous membranes or skin abrasions 2
  • Contact with reproductive materials during animal birthing events 5

High-risk populations include:

  • Agricultural workers, farmers, and animal caretakers 1
  • Water sports participants and those with recreational freshwater exposure 7, 6
  • Sewage and sanitary workers 1
  • Flood victims and disaster response personnel 1
  • Healthcare professionals and veterinarians 1

Clinical Presentation

The World Health Organization classifies leptospirosis into two main clinical forms: a mild to moderate flu-like illness (most common presentation) and a severe form characterized by hemorrhage, jaundice, and hepato-renal failure known as Weil's disease. 7

Biphasic clinical course: 2

Septicemic/bacteremic phase (4-7 days):

  • High fever (usually ≥39°C) 7
  • Severe diffuse myalgias, especially in the calves 7
  • Headache 7
  • Conjunctival suffusion (highly suggestive finding) 7, 6
  • Chills 7

Immune phase (severe disease - Weil's disease, occurring in approximately 5-10% of cases):

  • Jaundice 7, 6
  • Acute kidney failure 1, 3
  • Hemorrhagic manifestations 7, 3
  • Pulmonary hemorrhage and respiratory distress 1, 3
  • Hepatic dysfunction 3
  • Myocarditis or pericarditis (independently predictive of severe disease) 7
  • Aseptic meningitis (occurs in approximately 19% of cases) 7

Diagnostic Approach

Laboratory findings include:

  • Proteinuria and hematuria on urinalysis 7
  • Leukocytosis with polymorphonuclear predominance 7
  • Thrombocytopenia 8
  • Elevated bilirubin with mild transaminase elevation 7
  • Renal function abnormalities 7

Diagnostic confirmation methods:

  • Serology (most common method): IgM titers >1:320 are diagnostic; titers of 1:80-1:160 suggest early infection 7, 6
  • Convalescent serology: Repeat >10 days after symptom onset; fourfold or greater increase in titer confirms diagnosis 7, 6
  • Blood cultures: Most useful if obtained within first 5 days before antibiotics 7, 6
  • Nucleic acid amplification testing (NAAT): Turnaround time of 1-2 hours 7

Critical diagnostic pitfall: Serology is often negative in the first week, so treatment should not be delayed while waiting for confirmation. 6 Leptospirosis may be misdiagnosed as viral hepatitis in patients presenting with fever and jaundice. 7, 6

Treatment

For mild to moderate disease:

  • Doxycycline 100 mg orally twice daily for 7 days (treatment of choice) 7, 6
  • Alternative oral antibiotics include amoxicillin or tetracycline if doxycycline unavailable 6

For severe disease (Weil's disease):

  • Ceftriaxone 2g IV daily for 7 days (preferred regimen) 6
  • Penicillin G 1.5 million units IV every 6 hours (alternative) 6, 3
  • Third-generation cephalosporins or macrolides 3
  • Antibiotics must be started within 1 hour of recognition of severe sepsis/septic shock 7, 6
  • Standard course is 7 days, potentially extended to 10 days with slow clinical response 7

Supportive care for severe disease:

  • Aggressive IV fluid resuscitation with isotonic crystalloid or colloid (up to 60 ml/kg as three boluses of 20 ml/kg) 6
  • ICU admission for persistent hypoperfusion, shock, or multiorgan dysfunction 7, 6
  • Methylprednisolone 0.5-1.0 mg/kg IV daily for 1-2 weeks for respiratory complications 6

Special populations:

  • Children <8 years: Avoid doxycycline due to permanent tooth discoloration risk; use penicillin or ceftriaxone instead 6, 9
  • Pregnant women: Avoid tetracyclines and azoles; use penicillin or ceftriaxone 6

Prevention and Prophylaxis

Primary prevention measures:

  • Avoid contact with contaminated water, especially during floods 6, 9
  • Use protective equipment (boots, gloves) during high-risk occupational activities 9
  • Implement rodent control measures in endemic areas 9

Post-exposure prophylaxis:

  • Doxycycline 200 mg single dose orally provides 76.8% protection against leptospiral infection and 86.3% against clinical disease in flood victims 6, 9
  • Reserved for high-risk settings where attack rates exceed 10 cases per 100 person-years 9
  • Justified for military training in highly endemic areas or unavoidable prolonged water contact 9

Critical treatment principles: Treatment should be started immediately upon clinical suspicion without waiting for laboratory confirmation, as each hour of delay increases mortality. 7, 6 Clinical improvement should be expected within 3 days of antibiotic initiation, and the full course must be completed even with clinical improvement. 7, 6

References

Research

Leptospirosis: a neglected tropical zoonotic infection of public health importance-an updated review.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020

Research

Pathology and pathogenesis of human leptospirosis: a commented review.

Revista do Instituto de Medicina Tropical de Sao Paulo, 2018

Research

A global one health perspective on leptospirosis in humans and animals.

Journal of the American Veterinary Medical Association, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Leptospirosis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Leptospirosis Classification and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Leptospirosis Prophylaxis Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.